Published in J Biol Chem on June 25, 1982
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest (1989) 1.15
Acylation of 1-alkenyl-glycerophosphocholine and 1-acyl-glycerophosphocholine in guinea pig heart. Biochem J (1986) 0.97
Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. J Clin Invest (1988) 0.95
Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cells. Thromb Res (2006) 0.92
Lysophospholipase A2 activity in guinea-pig heart microsomal fractions displaying high activities with 2-acylglycerophosphocholines with linoleic and arachidonic acids. Biochem J (1989) 0.89
Purification of a lysophosphatidic acid-hydrolysing lysophospholipase from rat brain. Biochem J (1994) 0.84
The acylation of lysophosphoradylglycerocholines in guinea-pig heart mitochondria. Biochem J (1987) 0.84
Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs. J Clin Invest (1986) 0.84
Butyric acid-induced differentiation of HL-60 cells increases the expression of a single lysophospholipase. Biochem J (1992) 0.84
2-acyl-sn-glycero-3-phosphoethanolamine lysophospholipase A2 activity in guinea-pig heart microsomes. Biochem J (1991) 0.83
Regulation by vitamin E of phosphatidylcholine metabolism in rat heart. Biochem J (1987) 0.77
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Estimation of infarct size in man and its relation to prognosis. Circulation (1972) 4.19
Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest (1971) 3.11
Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal Biochem (2001) 3.09
Rubredoxin: a new electron transfer protein from Clostridium pasteurianum. Proc Natl Acad Sci U S A (1965) 2.55
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol (1992) 2.39
Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest (1973) 2.28
Activation of Raf-1 by 14-3-3 proteins. Nature (1994) 2.22
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol (1972) 2.19
Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc Natl Acad Sci U S A (1994) 2.12
Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation (1972) 2.10
Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res (1970) 2.02
Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2. J Biol Chem (1991) 2.00
Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med (1974) 1.92
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest (1972) 1.86
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res (1984) 1.83
High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization. Biochemistry (1984) 1.79
Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest (1972) 1.78
An improved basis for enzymatic estimation of infarct size. Circulation (1975) 1.77
Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry. J Am Soc Mass Spectrom (1995) 1.75
The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation (1979) 1.75
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69
The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2). J Biol Chem (2000) 1.67
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res (1978) 1.67
Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation (1976) 1.65
Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. J Biol Chem (1985) 1.65
Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol (1990) 1.65
Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol (1977) 1.65
On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging. J Am Coll Cardiol (1992) 1.62
Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation (1972) 1.60
Characteristics of Clostridium pasteurianum ferredoxin in oxidation-reduction reactions. Biochemistry (1966) 1.58
Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res (1972) 1.58
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med (1984) 1.57
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.55
Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol (1974) 1.51
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes (1994) 1.50
Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation (1972) 1.50
Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis. Circulation (1995) 1.49
Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Circulation (1989) 1.48
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation (1991) 1.47
Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest (1978) 1.45
Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O. J Am Coll Cardiol (1990) 1.44
Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert. Circulation (1996) 1.42
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J Clin Invest (1973) 1.42
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
Nonmonotonic alterations in the fluorescence anisotropy of polar head group labeled fluorophores during the lamellar to hexagonal phase transition of phospholipids. Biophys J (1992) 1.40
Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol (1975) 1.40
Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions. Cathet Cardiovasc Diagn (1998) 1.38
Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest (1978) 1.34
Ediortial: Isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction. Ann Intern Med (1973) 1.33
Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J (1984) 1.33
Influence of cardiac and respiratory motion on tomographic reconstructions of the heart: implications for quantitative nuclear cardiology. J Comput Assist Tomogr (1982) 1.31
Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum. Biochemistry (1985) 1.30
Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res (1975) 1.30
Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation (1981) 1.29
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation (1984) 1.27
Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol (1977) 1.27
Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry (1995) 1.25
Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation (2001) 1.24
Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation (1982) 1.24
Quantification of regional myocardial blood flow in vivo with H215O. Circulation (1984) 1.24
Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation (1978) 1.23
Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. Am J Cardiol (1976) 1.23
Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration. Biochemistry (1993) 1.22
Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science (1983) 1.22
Cloning and expression of a human 14-3-3 protein mediating phospholipolysis. Identification of an arachidonoyl-enzyme intermediate during catalysis. J Biol Chem (1992) 1.21
Thrombolysis, clot selectivity, and kinetics. Circulation (1984) 1.21
Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function. J Biol Chem (2000) 1.20
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation (1984) 1.18
Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis (1989) 1.17
Serum creatine phosphokinase (CPK ) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Experimental and clinical studies. Cardiovasc Res (1973) 1.16
Purification and characterization of canine myocardial cytosolic phospholipase A2. A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids. J Biol Chem (1990) 1.16
The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med (1987) 1.16
Expression, purification, and kinetic characterization of a recombinant 80-kDa intracellular calcium-independent phospholipase A2. J Biol Chem (1996) 1.16
Diabetes-induced changes in specific lipid molecular species in rat myocardium. Biochem J (2000) 1.15
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest (1989) 1.15
Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc Natl Acad Sci U S A (1989) 1.15
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes (2000) 1.14
Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool. Biochemistry (1996) 1.14
The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. J Clin Invest (1991) 1.14
Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation (1987) 1.13
Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label. Circulation (1992) 1.13
Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest (1983) 1.13
Depletion of intracellular calcium stores activates smooth muscle cell calcium-independent phospholipase A2. A novel mechanism underlying arachidonic acid mobilization. J Biol Chem (1997) 1.12
Cyclic adenosine monophosphate and cardiac contractility. Circ Res (1973) 1.12
Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation (1999) 1.12
Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium. J Clin Invest (1983) 1.09
Identification and purification of sheep platelet phospholipase A2 isoforms. Activation by physiologic concentrations of calcium ion. J Biol Chem (1986) 1.08
Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med (1976) 1.08
Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med (1989) 1.08
Left ventricular volume and ejection fraction determination by radionuclide angiography. Semin Nucl Med (1973) 1.07
Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol (1982) 1.06